Abstract
Background
Pituitary adenomas (PAs) are intracranial tumors, deriving from anterior pituitary cells. Previously, expression of non-metastasis-23 (NM23) gene has been shown to correlate with the progression of PAs. In this study, we aim to determine whether there is association between specific NM23 polymorphisms and invasive pituitary adenoma (IPA).
Methods
Genotypes of rs2302254 and rs16949649 of NM23 were identified in the peripheral venous blood of patients by PCR-RLFP. Next, the correlation between specific genotypes of rs2302254 and rs16949649 and risk of IPA was investigated. Finally, the correlations between NM23 polymorphisms and tumor size, Ki67 LI and recurrence of IPA were analyzed with 3 to 24 months follow-up for the enrolled patients.
Results
We observed that the TT genotype at rs16949649 correlated closely with a high risk of IPA, while CC and CT genotypes reduced the risk of IPA. CC genotype at rs2302254 increased the risk of IPA, while CT and TT genotypes reduced the risk of IPA. Trs16949649Crs2302254 haplotype of NM23 was found to be a high-risk haplotype for IPA. TT genotype at rs16949649 and CC genotype at rs2302254 were associated with higher rates of tumors larger than 20 mm, Ki67 LI and tumor recurrence.
Conclusion
Taken together, the present study provides evidence that NM23 polymorphisms are closely associated with the incidence and recurrence of IPA. Specifically, TT genotype at rs16949649 and CC genotype at rs2302254 are risk factors of IPA. NM23 polymorphisms could therefore be used as a reference for clinical diagnosis and prognosis of IPA.
Similar content being viewed by others
References
Wu JL, Qiao JY, Duan QH (2016) Significance of TNF-alpha and IL-6 expression in invasive pituitary adenomas. Genet Mol Res. https://doi.org/10.4238/gmr.15017502
Lan X, Gao H, Wang F, Feng J, Bai J, Zhao P, Cao L, Gui S, Gong L, Zhang Y (2016) Whole-exome sequencing identifies variants in invasive pituitary adenomas. Oncol Lett 12(4):2319–2328
Ji-Hu Y, Guo-Dong H, Tao J, Hai-Dong W, Yu-Fei L, Jian G, Zhen L, Wei-Ping L (2018) Endoscopic endonasal surgery treatment strategies for invasive pituitary adenoma: analysis of four approaches. World Neurosurg 115:5–13
Liu C, Gao H, Cao L, Gui S, Liu Q, Li C, Li D, Gong L, Zhang Y (2016) The role of FSCN1 in migration and invasion of pituitary adenomas. Mol Cell Endocrinol 419:217–224
Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15(1):71–83
Gao H, Xue Y, Cao L, Liu Q, Liu C, Shan X, Wang H, Gu Y, Zhang Y (2017) ESR1 and its antagonist fulvestrant in pituitary adenomas. Mol Cell Endocrinol 443:32–41
Zhong CH, Tao B, Wu Y, Peng LL, Zhou PZ, Chen LG, Jiang S (2015) The Role of cancer-associated fibroblasts in invasive behavior of pituitary adenoma. Sichuan Da Xue Xue Bao Yi Xue Ban 46(5):673–678
Boissan M, De Wever O, Lizarraga F, Wendum D, Poincloux R, Chignard N, Desbois-Mouthon C, Dufour S, Nawrocki-Raby B, Birembaut P, Bracke M, Chavrier P, Gespach C, Lacombe ML (2010) Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res 70(19):7710–7722
Jarrett SG, Novak M, Dabernat S, Daniel JY, Mellon I, Zhang Q, Harris N, Ciesielski MJ, Fenstermaker RA, Kovacic D, Slominski A, Kaetzel DM (2012) Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis. Cancer Res 72(1):133–143
Buxton IL, Yokdang N (2011) Extracellular NM23 signaling in breast cancer: incommodus verum. Cancers 3(3):2844–2857
Boissan M, Lacombe ML (2012) NM23, an example of a metastasis suppressor gene. Bull Cancer 99(4):431–440
Li Y, Kang S, Qin JJ, Wang N, Zhou RM, Sun HY (2012) nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease. Gynecol Oncol 126(3):455–459
Li AL, Zhou X, Wang ZN, Song YX, Gao P, Miao Y, Zhu JL, Xu HM (2012) Associations of non-metastatic cells 1 gene polymorphisms with lymph node metastasis risk of gastric cancer in Northern Chinese population. Tumour Biol 33(6):2159–2166
Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr (2002) The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 96(2):195–208
Negm HM, Al-Mahfoudh R, Pai M, Singh H, Cohen S, Dhandapani S, Anand VK, Schwartz TH (2017) Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas. J Neurosurg 127(2):397–408
Qu S, Long J, Cai Q, Shu XO, Cai H, Gao YT, Zheng W (2008) Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival. Clin Cancer Res 14(15):4787–4793
Huang XI, Zhao W, Li Y, Kang S (2015) Association between nm23 gene polymorphisms and the risk of endometriosis. Biomed Rep 3(6):874–878
Takino H, Herman V, Weiss M, Melmed S (1995) Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. J Clin Endocrinol Metab 80(5):1733–1738
Feng CY, Wang PH, Tsai HT, Tee YT, Ko JL, Chen SC, Lin CY, Han CP, Yang JS, Liu YF, Lin LY, Yang SF (2010) Polymorphisms of human nonmetastatic clone 23 type 1 gene and neoplastic lesions of uterine cervix. Reprod Sci 17(10):886–893
Fang M, Tao Y, Liu Z, Huang H, Lao M, Huang L, Zhu B (2017) Meta-analysis of the relationship between NM23 expression to gastric cancer risk and clinical features. Biomed Res Int 2017:8047183
Wu HW, Gao LD, Wei GH (2013) hMSH2 and nm23 expression in sporadic colorectal cancer and its clinical significance. Asian Pac J Cancer Prev 14(3):1995–1998
Altas M, Bayrak OF, Ayan E, Bolukbasi F, Silav G, Coskun KK, Culha M, Sahin F, Sevli S, Elmaci I (2010) The effect of polymorphisms in the promoter region of the MMP-1 gene on the occurrence and invasiveness of hypophyseal adenoma. Acta Neurochir 152(9):1611–1617 (Discussion 1617)
Acknowledgements
We would like to give our sincere appreciation to the reviewers for their helpful comments on this article.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have declared that no conflicting interests exist.
Ethics approval
The study was conducted with the approval of the Ethics Committee of Chifeng Municipal Hospital. Written informed consents were signed by all participating patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, H., Sang, W. Association of NM23 polymorphisms and clinicopathological features and recurrence of invasive pituitary adenomas. Pituitary 23, 113–119 (2020). https://doi.org/10.1007/s11102-019-01006-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-019-01006-1